A Type I Insulin-Like Growth Factor Receptor Kinase Inhibitor (PQIP) Enhances the Cytotoxicity of Doxorubicin in Human Cancer Cell Lines.

被引：0
|
作者：
Zeng, X.
Buck, E.
Yee, D.
机构：
[1] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA
[2] OSI Pharmaceut Inc, Farmingdale, NY USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：859S / 860S
页数：2
相关论文
共 50 条
  • [1] The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models
    Flanigan, Sara A.
    Pitts, Todd M.
    Eckhardt, S. Gail
    Tentler, John J.
    Tan, Aik Choon
    Thorburn, Andrew
    Leong, Stephen
    CLINICAL CANCER RESEARCH, 2010, 16 (22) : 5436 - 5446
  • [2] Insulin-like growth factor expression in human cancer cell lines
    Quinn, KA
    Treston, AM
    Unsworth, EJ
    Miller, MJ
    Vos, M
    Grimley, C
    Battey, J
    Mulshine, JL
    Cuttitta, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) : 11477 - 11483
  • [3] Insulin-like growth factor-I receptor activation blocks doxorubicin cytotoxicity in sarcoma cells
    Beech, DJ
    Perer, E
    Helms, J
    Gratzer, A
    Deng, N
    ONCOLOGY REPORTS, 2003, 10 (01) : 181 - 184
  • [4] Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer
    Resnik, JL
    Reichart, DB
    Huey, K
    Webster, NJG
    Seely, BL
    CANCER RESEARCH, 1998, 58 (06) : 1159 - 1164
  • [5] Insulin-like growth factor receptor type I as a target for cancer therapy
    Goetsch, Liliane
    Corvaia, Nathalie
    IMMUNOTHERAPY, 2009, 1 (02) : 265 - 279
  • [6] Type I insulin-like growth factor receptor function in breast cancer
    Ewa Surmacz
    Marina A. Guvakova
    Mary K. Nolan
    Roberto F. Nicosia
    Laura Sciacca
    Breast Cancer Research and Treatment, 1998, 47 : 255 - 267
  • [7] Type I insulin-like growth factor receptor function in breast cancer
    Surmacz, E
    Guvakova, MA
    Nolan, MK
    Nicosia, RF
    Sciacca, L
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (03) : 255 - 267
  • [8] Type I insulin-like growth factor receptor as a therapeutic target in cancer
    Miller, BS
    Yee, D
    CANCER RESEARCH, 2005, 65 (22) : 10123 - 10127
  • [9] Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol
    Beech, DJ
    Parekh, N
    Pang, Y
    ONCOLOGY REPORTS, 2001, 8 (02) : 325 - 329
  • [10] How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
    Xu, Yibin
    Margetts, Mai B.
    Venugopal, Hari
    Menting, John G.
    Kirk, Nicholas S.
    Croll, Tristan I.
    Delaine, Carlie
    Forbes, Briony E.
    Lawrence, Michael C.
    STRUCTURE, 2022, 30 (08) : 1098 - +
12345